Karachaliou, Georgia Sofia <br/><br/>
Chemotherapy Following PD-1 Inhibitor Blockade in Patients with Unresectable Stage III/Stage IV Metastatic Melanoma: A Single Academic Institution Experience.  [electronic resource] 

 -  Oncology  2020 
 - 174-178 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1423-0232 
<br/><br/><label>Standard No.: </label>10.1159/000504578  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Academic Medical Centers<br/>Adult<br/>Aged<br/>Antineoplastic Agents, Alkylating--adverse effects<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Disease Progression<br/>Female<br/>Humans<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Neoplasm Staging<br/>North Carolina<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Progression-Free Survival<br/>Retrospective Studies<br/>Risk Factors<br/>Skin Neoplasms--drug therapy<br/>Temozolomide--adverse effects<br/>Time Factors